Private Wealth Management Group, LLC Avidity Biosciences, Inc. Transaction History
Private Wealth Management Group, LLC
- $363 Billion
- Q3 2025
A detailed history of Private Wealth Management Group, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 121 shares of RNA stock, worth $8,566. This represents 0.0% of its overall portfolio holdings.
Number of Shares
121
Previous 122
0.82%
Holding current value
$8,566
Previous $3.47 Million
52.15%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RNA
# of Institutions
312Shares Held
139MCall Options Held
1.24MPut Options Held
531K-
Janus Henderson Group PLC London, X014.5MShares$1.03 Billion0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$936 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY11.4MShares$805 Million6.62% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$713 Million0.08% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.79MShares$693 Million0.05% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $3.69B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...